Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/04/2002 | WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
04/04/2002 | WO2000064261A9 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof |
04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
04/04/2002 | US20020040009 Novel ratA |
04/04/2002 | US20020040008 Administering agent for inhibiting interaction between P-selectin and a ligand of P-selectin |
04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
04/04/2002 | US20020039778 Isolated and purified DNA molecule and protein for the degradation of triazine compounds |
04/04/2002 | US20020039776 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
04/04/2002 | US20020039588 Compounds and methods for the treatment and prevention of bacterial infection |
04/04/2002 | US20020039581 Antibodies against CTLA4 and uses therefor |
04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
04/04/2002 | CA2423953A1 Hydrolases |
04/04/2002 | CA2423922A1 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
04/04/2002 | CA2423797A1 Antibodies to the propeptide of candida albicans and methods of use |
04/04/2002 | CA2423708A1 Method for producing human anti-thymocyte immunoglobulins |
04/04/2002 | CA2423704A1 G-protein coupled receptors |
04/04/2002 | CA2423701A1 Oxidoreductases |
04/04/2002 | CA2423694A1 Transferases |
04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
04/04/2002 | CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same |
04/04/2002 | CA2423492A1 A fibrin/fibrinogen-binding conjugate |
04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
04/04/2002 | CA2423424A1 Secreted proteins |
04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
04/04/2002 | CA2422890A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
04/04/2002 | CA2422099A1 Identification of neuroblastoma tumor suppressor genes |
04/04/2002 | CA2421680A1 Antibodies for human cytochrome p450 2d6 |
04/04/2002 | CA2420475A1 Ige receptor antagonists |
04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
04/03/2002 | EP1192278A1 48 human secreted proteins |
04/03/2002 | EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase |
04/03/2002 | EP1192260A2 Arabidopsis thaliana cdc7 and cdc27 homologs |
04/03/2002 | EP1192259A1 Tankyrase2 materials and methods |
04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
04/03/2002 | EP1192254A1 Helical polypeptide zalpha29 |
04/03/2002 | EP1192253A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
04/03/2002 | EP1192252A2 Secreted protein zacrp4 |
04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
04/03/2002 | EP1192249A1 47 human secreted proteins |
04/03/2002 | EP1192247A1 Sphingosine kinase enzyme |
04/03/2002 | EP1192185A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
04/03/2002 | EP1192183A2 Diagnostic test for thrombotic or thromboembolic disease |
04/03/2002 | EP1192180A1 Product from starfish |
04/03/2002 | EP1192176A1 49 human secreted proteins |
04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
04/03/2002 | EP1192171A1 48 human secreted proteins |
04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
04/03/2002 | EP1191839A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
04/03/2002 | EP0788508A4 Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors |
04/03/2002 | EP0775199B1 Superoxide dismutase-4 |
04/03/2002 | EP0722489B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
04/03/2002 | EP0666868B1 Use of anti-VEGF antibodies for the treatment of cancer |
04/03/2002 | EP0621786B1 Induced tolerance to xenografts |
04/03/2002 | CN1343221A Polypeptide variants with altered effector function |
04/03/2002 | CN1342770A Polypeptide-human protein 10.01 containing phe-His aminolyase active site and polynucleotide for coding it |
04/03/2002 | CN1342769A Polypeptide-matric metalloprotease cysteine switch 10.78 and polynucleotide for coding it |
04/03/2002 | CN1342768A Polypeptide-dipeptidyl peptidase IV protein 27.5 and polynucleotide for coding it |
04/03/2002 | CN1342767A Polypeptide-human phosphatidase 10.67 and polynucleotide for coding it |
04/03/2002 | CN1342766A Polypeptide-phosphatidase A2-18.59 and polynucleotide for coding it |
04/03/2002 | CN1342765A Polypeptide-human receptor associated tyrosine kinase 8.91 and polynucleotide for coding it |
04/03/2002 | CN1342764A Polypeptide-tRNA guanine glycotransferase 24.75 and polynucleotide for coding it |
04/03/2002 | CN1342763A Polypeptide-colipase 9.79 and polynucleotide for coding it |
04/03/2002 | CN1342762A Polypeptide-human protein 32.67 containing enoyl-CoA hydratase characteristic sequence fragment and polynucleotide for coding it |
04/03/2002 | CN1342761A Polypeptide-phosphoglyceromutase 10.56 and polynucleotide for coding it |
04/03/2002 | CN1342760A Polypeptide-threonine synthetase 13.75 and polynucleotide for coding it |
04/03/2002 | CN1342759A Polypeptide-human reverse transcriptase 12.76 and polynucleotide for coding it |
04/03/2002 | CN1342758A Polypeptide-reverse transcriptase 9.24 and polynucleotide for coding it |
04/03/2002 | CN1342757A Polypeptide-human threonine-tRNA synthetase 16.83 and polynucleotide for coding it |
04/03/2002 | CN1342712A Polypeptide-human actin-binding protein 51.37 containing PDZ structure domain and polynucleotide for coding it |
04/03/2002 | CN1342711A Polypeptide-human macroprotein 16.39 and polynucleotide for coding it |
04/03/2002 | CN1342709A Polypeptide-human EF-chiral calbindin 36.85 containing ATP/GTP binding structure domain and polynucleotide for coding it |
04/03/2002 | CN1342708A Polypeptide-human macroprotein 0273-58.19 and polynucleotide for coding it |
04/03/2002 | CN1342707A Polypeptide-human macroprotein 0273-72.82 and polynucleotide for coding it |
04/03/2002 | CN1342706A Polypeptide-human tumor suppressor protein DICEI-98-61.27 and polynucleotide for coding it |
04/03/2002 | CN1342705A Polypeptide-neurodevelopment associated protein 135.63 and polynucleotide for coding it |
04/03/2002 | CN1342704A Polypeptide-human macroprotein 69.19 and polynucleotide for coding it |
04/03/2002 | CN1342703A Polypeptide-human protein 11.93 containing porin characteristic sequence fragment and polynucleotide for coding it |
04/03/2002 | CN1342702A Polypeptide-human breast susceptible gene coded protein 10.45 and polynucleotide for coding it |
04/03/2002 | CN1342700A Polypeptide-human zinc finger protein 44.22 and polynucleotide for coding it |
04/03/2002 | CN1342699A Polypeptide-mouse polycomb gene enhancer 84-57.31 and polynucleotide for ccoding it |
04/03/2002 | CN1342698A Polypeptide-human zinc finger protein 74.25 and polynucleotide for coding it |
04/03/2002 | CN1342697A Polypeptide-human protein 35.42 containing pfkB protein family characteristic sequence fragment and polynucleotide for coding it |
04/03/2002 | CN1342696A Polypeptide-human DnaJ protein 46.53 and polynucleotide for coding it |
04/03/2002 | CN1342695A Polypeptide-human macroprotein 0273-23.98 and polynucleotide for coding it |
04/03/2002 | CN1342694A Polypeptide-human P24 protein 11.99 and polynucleotide for coding it |
04/03/2002 | CN1342693A Polypeptide-human vesicular transport associated protein 9.13 and polynucleotide for coding it |
04/03/2002 | CN1342692A Polypeptide-mouse brain polyose 64-31.79 and polynucleotide for coding it |
04/03/2002 | CN1342691A Polypeptide-human signal recognition protein 10.23 and polynucleotide for coding it |